Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients?

被引：1
|
作者：
Germani, Giacomo [1 ,2 ]
Tsochatzis, Emmanuel [1 ]
Burroughs, Andrew Kenneth [1 ]
机构：
[1] Royal Free Sheila Sherlock Liver Ctr & Univ, Royal Free Hosp, Dept Surg, London, England
[2] Padua Univ Hosp, Dept Surg & Gastroenterol Sci, Padua, Italy
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷 / 09期
关键词：
HEPATITIS-C; MYCOPHENOLATE-MOFETIL; AZATHIOPRINE; IMPACT;
D O I：
10.1111/j.1432-2277.2011.01288.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E77 / E78
页数：2
相关论文
共 50 条
  • [1] PROTOCOL LIVER BIOPSIES IN HCV TRANSPLANT RECIPIENTS: PROGRESSION OF FIBROSIS
    De Martin, Eleonora
    Senzolo, Marco
    Boninsegna, Sara
    Guido, Maria
    Gambato, Martina
    Germani, Giacomo
    Masier, Annalisa
    Russo, Francesco P.
    Zanus, Giacomo
    Cillo, Umberto
    Burra, Patrizia
    LIVER TRANSPLANTATION, 2008, 14 (07) : S207 - S207
  • [2] Does haemophilia slow down the development of liver fibrosis?
    van Dievoet, Marie-Astrid
    Leclercq, Isabelle
    Hermans, Cedric
    Lambert, Catherine
    Horsmans, Yves
    Jacquemin, Marc
    Eeckhoudt, Stephane
    HAEMOPHILIA, 2019, 25 (01) : E32 - E35
  • [3] SERUM MICRORNA PREDICT FIBROSIS IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE AFTER TREATMENT WITH DAAS: A PILOT STUDY
    Magro, B.
    Barbera, F.
    Seidita, A.
    Tuzzolino, F.
    Gruttadauria, S.
    Conaldi, P. G.
    Pietrosi, G.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S108 - S108
  • [4] Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Molmenti, EP
    Klintmalm, GB
    TRANSPLANTATION, 2000, 69 (08) : S120 - S120
  • [5] Progression of Fibrosis in Maintenance Liver Transplant Recipients with HCV Recurrence Converted to Everolimus: Results of a Multicenter, Randomized, Controlled Study
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Wang, Y.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 84 - 84
  • [6] Mycophenolate mofetil (MMF) in pediatric liver transplant recipients
    Dhawan, A
    Lewis, PN
    Heaton, ND
    Baker, AJ
    Rela, M
    Hadzic, N
    Srinivasan, P
    MieliVergani, G
    HEPATOLOGY, 1997, 26 (04) : 1487 - 1487
  • [7] The association between MMF and risk of progressive renal dysfunction and death in adult liver transplant recipients with HCV
    Lake, John
    Patel, Dharmesh
    David, Kristin
    Richwine, Jason
    Morris, Jonathan
    CLINICAL TRANSPLANTATION, 2009, 23 (01) : 108 - 115
  • [8] PROGRESSION OF FIBROSIS IN HCV plus LIVER TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE OR TACROLIMUS
    Nevens, Frederik
    Klintmalm, Goran
    Villamil, Federico G.
    Jones, Robert
    Clavien, Pierre-Alain
    Metselaar, Herold J.
    Prestele, Hans
    Orsenigo, Roberto
    Levy, Gary
    TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [9] IMPACT OF SIROLIMUS BASED IMMUNOSUPPRESSION ON FIBROSIS PROGRESSION IN HCV LIVER TRANSPLANT RECIPIENTS
    Nandy, Nina
    Rogers, Christin
    Nasser, Imad
    Challies, Tracy L.
    Karp, Seth
    Johnson, Scott
    Hanto, Douglas W.
    Curry, Michael P.
    HEPATOLOGY, 2010, 52 (04) : 395A - 395A
  • [10] Female HCV cirrhosis liver transplant recipients have worse fibrosis progression due to recurrent HCV than male HCV recipients
    Cholongitas, E.
    Belli, L. S.
    Samonakis, D.
    Burra, P.
    Alberti, A. B.
    Zavaglia, C.
    Quaglia, A.
    Fagiuoli, S.
    Vangeli, M.
    De Carlis, L.
    Boninsegna, S.
    Patch, D.
    Davidson, B. R.
    Rolles, K.
    Cillo, U.
    Camma, C.
    Burroughs, A. K.
    Pinzello, G.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S58 - S58
12345